Probiotic products for babies and young children are extensively marketed, with claims spanning colic relief, immune support, eczema prevention, digestive health, and beyond. Some of these claims have meaningful research support; many do not. The evidence base for infant probiotics is genuinely complex — it is strain-specific, condition-specific, and in many cases still evolving.
Understanding what the current evidence shows, and what distinguishes a probiotic with genuine research support from one whose marketing exceeds its evidence, allows parents to make better-informed decisions about whether and which probiotic to use.
Healthbooq provides parents with evidence-based guidance on infant health and nutrition, cutting through marketing claims to focus on what the research actually shows.
What Probiotics Are
Probiotics are live microorganisms — primarily bacteria, occasionally yeasts — that when consumed in sufficient quantities may provide health benefits. The most commonly used probiotics for infants belong to the Lactobacillus and Bifidobacterium genera. An important principle in probiotic research is strain specificity: the effects of one strain of Lactobacillus rhamnosus cannot be assumed to apply to another strain of the same species, let alone to Lactobacillus acidophilus. Products often list genus and species (Lactobacillus reuteri) but not strain (DSM 17938), making it difficult for parents to assess whether a product matches the research.
What the Evidence Supports
The best-supported use of infant probiotics is for colic in breastfed babies. Multiple randomised controlled trials have found that Lactobacillus reuteri DSM 17938 reduces daily crying time in breastfed infants with colic by around an hour per day compared to placebo. The effect is modest but meaningful for exhausted parents. Notably, this effect has been demonstrated in breastfed infants specifically; evidence for formula-fed infants is less consistent.
For antibiotic-associated diarrhoea — loose stools during or after a course of antibiotics — certain strains, including Lactobacillus rhamnosus GG and Saccharomyces boulardii, have evidence of benefit from paediatric trials. Given that many young children receive multiple antibiotic courses in their first years, this is a practically relevant application.
The evidence for probiotics in eczema prevention is mixed and currently insufficient to support a clear recommendation. Some trials of specific strains in high-risk infants (with a family history of allergy) suggest modest preventive effects, but guidelines do not currently recommend probiotics for eczema prevention as standard practice.
The Infant Microbiome and Early Life
The gut microbiome in infancy is shaped by factors including mode of birth (vaginal versus caesarean), feeding method (breastfed versus formula-fed), early antibiotic exposure, diet after weaning, and the home environment. Breast milk is itself a significant source of microorganisms — as well as human milk oligosaccharides (HMOs) that selectively feed beneficial bacteria — and breastfed infants tend to have different microbiome compositions than formula-fed infants, with more Bifidobacteria. Whether these differences have long-term health implications is an active area of research.
Practical Guidance
Probiotics are generally safe in healthy term infants. They are not recommended for premature infants or immunocompromised children without specialist guidance, as there are case reports of infections in these higher-risk groups. If considering a probiotic for colic, look specifically for products containing Lactobacillus reuteri DSM 17938 — this is the strain with the best evidence for this indication. Generic multi-strain products with no identified strain information cannot be assessed against the research.
Key Takeaways
Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. The evidence for their use in infants and young children is variable by condition and strain: there is reasonably good evidence for Lactobacillus reuteri DSM 17938 in reducing crying time in breastfed colicky infants; some evidence for certain strains in preventing antibiotic-associated diarrhoea; and limited or inconsistent evidence for prevention of eczema, respiratory illness, and other conditions. Probiotics are generally safe in healthy term infants. Parents considering probiotics should look for specific strains with supporting evidence rather than generic products.
